{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:43:53Z","timestamp":1785519833996,"version":"3.56.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T00:00:00Z","timestamp":1475712000000},"content-version":"vor","delay-in-days":279,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["currenttherapeuticres.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/j.curtheres.2016.12.001","type":"journal-article","created":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T07:22:23Z","timestamp":1482304943000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study"],"prefix":"10.1016","volume":"81-82","author":[{"given":"Yoshikazu","family":"Kinoshita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuuichi","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Shiino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Kudou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Iwakiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Umegaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Ashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.curtheres.2016.12.001_bib1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1572-0241.2001.03511.x","article-title":"Nonerosive reflux disease--current concepts and dilemmas","volume":"96","author":"Fass","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.curtheres.2016.12.001_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2036.2009.04021.x","article-title":"Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease","volume":"30","author":"Lee","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.curtheres.2016.12.001_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1440-1746.2007.05249.x","article-title":"Asia-Pacific consensus on the management of gastroesophageal reflux disease: update","volume":"23","author":"Fock","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.curtheres.2016.12.001_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2036.2007.03350.x","article-title":"Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan","volume":"26","author":"Miwa","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.curtheres.2016.12.001_bib5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1124\/jpet.111.185314","article-title":"Characterization of a novel potassium-competitive acid blocker of the gastric H,K-ATPase, 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamin e monofumarate (TAK-438)","volume":"339","author":"Shin","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.curtheres.2016.12.001_bib6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/apt.13461","article-title":"Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis","volume":"43","author":"Ashida","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.curtheres.2016.12.001_bib7","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1136\/gutjnl-2015-311304","article-title":"Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study","volume":"65","author":"Murakami","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.curtheres.2016.12.001_bib8","unstructured":"Takeda Takecab (vonoprazan tablets) package insert. Available at: http:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuDetail\/ResultDataSetPDF\/400256_2329030F1020_1_04. Accessed 28 Sep 2016."},{"issue":"1","key":"10.1016\/j.curtheres.2016.12.001_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1124\/jpet.110.170274","article-title":"1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamin e monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases","volume":"335","author":"Hori","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.curtheres.2016.12.001_bib10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1124\/jpet.111.179556","article-title":"A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animals","volume":"337","author":"Hori","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.curtheres.2016.12.001_bib11","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1038\/ctg.2015.18","article-title":"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese\/non-Japanese Subjects","volume":"6","author":"Sakurai","year":"2015","journal-title":"Clin Transl Gastroenterol"},{"issue":"2","key":"10.1016\/j.curtheres.2016.12.001_bib12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00535-006-1775-4","article-title":"Minimal changes in reflux esophagitis: red ones and white ones","volume":"41","author":"Hongo","year":"2006","journal-title":"J Gastroenterol"},{"issue":"7","key":"10.1016\/j.curtheres.2016.12.001_bib13","first-page":"655","article-title":"Efficacy and safety of lansoprazole (AG-1749) 15 mg and 30 mg in Japanese patients with non-erosive reflux disease (NERD) - a phase III multicenter, double-blind, placebo-controlled trial","volume":"36","author":"Hongo","year":"2008","journal-title":"Jpn Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.curtheres.2016.12.001_bib14","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s10620-012-2087-6","article-title":"A study on the efficacy of rebamipide for patients with proton pump inhibitor-refractory non-erosive reflux disease","volume":"57","author":"Adachi","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.curtheres.2016.12.001_bib15","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1440-1746.2011.06975.x","article-title":"Predicting the efficacy of proton pump inhibitors in patients with non-erosive reflux disease before therapy using dual-channel 24-h esophageal pH monitoring","volume":"27","author":"Shimatani","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"issue":"15","key":"10.1016\/j.curtheres.2016.12.001_bib16","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.2169\/internalmedicine.49.3615","article-title":"Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy","volume":"49","author":"Miyamoto","year":"2010","journal-title":"Intern Med"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X1630100X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X1630100X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T17:16:47Z","timestamp":1658251007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X1630100X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":16,"alternative-id":["S0011393X1630100X"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2016.12.001","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2016.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}